6,678 trials
Rheumatoid Arthritis
Primary: Number of Participants Reporting Adverse Events (AEs) — 11; 7 number of participants
Attention-deficit/Hyperactivity Disorder
Primary: Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 6 — -17; -25.4; -22.1 units on a scale…
Photodamaged Skin
Primary: Change From Baseline in Investigator Global Assessment (IGA) of Participant's Overall Facial Appearance at Week 24 — 6.04; 5.81; 0.6; 0.7 units on scale — p=0.358
Pain
Primary: To Determine if a Difference in Pain Scale Ratings is Detectable Following Intramuscular Palivizumab Injection That Was Pre-treated With Placebo or Tetracaine. — 7.3…
Smoking · Smoking Cessation · Motivation
Primary: Percent Change in Cigarettes Smoked Per Day (CPD) — 38.7; 38.9; 37.4; 40.2 Percent Change in cigarettes per day — p=.98
Full Thickness Rotator Cuff Tears
Primary: Change in Range of Motion (ROM)From Baseline to 24 Months — 124.4; 120.2; 73.2; 84.1 degrees
Anaesthesia · Cataract
Primary: Time Taken to Achieve Adequate Akinesia — 41; 41; 9; 9 participants
Smoking · Smoking Cessation · Nicotine Dependence
Primary: Self-Reported 7-Day Point-Prevalence Abstinence — 208; 209; 201; 216 participants — p=.341
Type 2 Diabetes
Primary: Non-inferiority of HbA1C Change From Baseline in Vildagliptin + Metformin Group Compared With Pioglitazone + Metformin Group — -0.94; -0.60 % (change of HbA1c)
Type 2 Diabetes · Healthy · Impaired Glucose Tolerance
Primary: Effect of Pioglitazone, Exenatide and Combined Pioglitazone and Exenatide on Body Weight — 5.5; 2.4; 2.7 kg — p=<0.05
Depressive Disorder · Parkinson Disease
Primary: Inventory of Depressive Symptomatology- Clinician Rated (IDS-C) Scale — 22.7; 9.5 percentage of improved participants
Vision
Primary: Change From Baseline in Color Vision Discrimination 1 Hour Post Dosing — 0.1; -0.4; -0.2; -0.5 total error score — p=0.8216
Rheumatoid Arthritis
Primary: Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Rheumatoid Arthritis Magnetic Resonance Imaging Scoring System (RAMRIS) Synovitis Score — 3.4; 2.3…
Smoking Cessation · Bipolar Disorder
Primary: 7-day Prevalence of Abstinence From Cigarette Smoking at 12 Weeks — 15; 3 participants
Purpura, Thrombocytopaenic, Idiopathic
Primary: Number of Participants With Bone Marrow (BM) Fibers of MF Grade 0, 1, 2 and 3 on the European Consensus (EC) Scale at Baseline — 150; 9; 0; 0 Participants